The Self-assembling peptide P11-4 influences viability and osteogenic differentiation of stem cells of the apical papilla (SCAP).

OBJECTIVE: To analyze the effect of P11-4 self-assembly peptide on cell viability and osteogenic capacity of SCAPs through mineral deposition and gene expression of osteogenic markers. METHODS: SCAPs were seeded in contact with P11-4 (10 µg/ml, 100 µg/ml and 1 mg/ml) solution. Cell viability was evaluated using a colorimetric assay MTT: 3-(4,5-dimethyl-thiazolyl-2)-2,5- diphenyltetrazolium bromide) in an experimental time of 24, 48 and 72 h (n = 7). Mineral deposition and quantification provided by the cells was tested using the Alizarin Red staining and Cetylpyridinium Chloride (CPC), respectively, after 30 days (n = 4). Gene expression of Runt-related transcription factor 2 (RUNX2), Alkaline phosphatase (ALP) and Osteocalcin (OCN) was quantified using quantitative polymerase chain reaction (RT-qPCR), at 3 and 7 days with Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as the housekeeping gene, and relative gene expression was measured using the ΔΔCq method. Data were analyzed using Kruskall-Wallis followed by multiple comparisons, and T-test for gene expression with α=0.05. RESULTS: All tested concentrations (10 µg/ml, 100 µg/ml and 1 mg/ml) were not cytotoxic at time 24 and 48 h. After 72 h, a slight decrease in cell viability was observed for the lowest concentration (10 µg/ml). The concentration of 100 µg/ml P11-4 showed the highest mineral deposition. However, qPCR analysis of P11-4 (10 µg/ml) showed upregulation of RUNX2 and OCN at 3 days, with downregulation of ALP at 3 and 7d CONCLUSION: P11-4 did not affect cell viability, induced mineral deposition in SCAPs, and upregulated the expression of RUNX2 and OCN genes at 3 days, while downregulating ALP expression at 3 and 7 days. CLINICAL SIGNIFICANCE: Based on the results obtained in this study it can be stated that self-assembling peptide P11-4 is a potential candidate to induce mineralization on dental stem cells for regenerative purposes and also for a clinical use as a capping agent without compromising the cells health.

Should Advanced Friedreich's Ataxia Be a Contraindication for Heart Transplantation? A Case Report of a Successful Procedure in a 58-Year-Old Patient.

The information on heart transplantation (HT) in patients with Friedreich's Ataxia (FA) is scarce, and the few published case reports are limited to young patients with mild neurological manifestations. We present the case of a 58-year-old patient with advanced FA (Scale for the Assessment and Rating of Ataxia [SARA] score 30/40), wheelchair-bound for the last 16 years and had urinary incontinence, dysarthria, and neurosensorial deafness. The patient was admitted for a refractory arrhythmic storm and had previous hypertrophic cardiomyopathy that evolved to dilated cardiomyopathy with severely reduced left ventricular ejection fraction and recurrent ventricular arrhythmias. A multidisciplinary team discussed the HT option. The patient was aware of the risks and benefits and considered worthy of the intervention, so he was listed for HT. After a successful surgical intervention, the patient had a long postoperative stay in ICU. He required a high dose of vasopressors, underwent hemofiltration for one month, suffered critical illness myopathy, had several respiratory infections and delayed tracheal extubation. Two and a half months after HT and almost five months at the hospital, the patient was successfully discharged. FA patients with severe heart conditions should be carefully evaluated by a multidisciplinary team to decide the candidacy for HT.

Immunologic Abnormalities Associated With Health Status of Heart Recipients Long Term After Transplantation.

BACKGROUND: With improvements in survival rates, health-related quality of life is an important outcome parameter to evaluate the effectiveness of transplantation. We aimed to identify potential immunologic abnormalities as factors associated with poorer health-related quality of life at distinct scales of the 36-Item Short Form Health Survey in heart transplant recipients long term after transplantation. METHODS: One hundred heart transplant recipients were evaluated in a single center. Short-form 36 questionnaires were sent by mail to participants. All patients were clinically and immunologically evaluated after the first year of heart transplantation. RESULTS: A high prevalence of several immunologic abnormalities persisted even after the first year of transplantation, including IgG hypogammaglobulinemia, low IgG-specific antipneumococcal antibodies, C4 hypocomplementemia, CD8 T-cell lymphocytopenia, and CD19 B-cell lymphocytopenia. Older recipients (>55 years), posttransplant diabetes, digestive complications, and posttransplant infections were associated with lower physical functioning scores (scale < 60). Older recipients (>55 years), pretransplant diabetes, pretransplant arterial hypertension, posttransplant digestive complications, and lower CD8 counts were associated with lower physical role scores (scale <25). CONCLUSION: In a single center study, lower CD8 cell counts were found to be associated with poorer health status in heart recipients after the first year of transplantation.

Homemade masks in the COVID-19 pandemic: recommendations, physical characteristics, disinfection and efficacy of use / Mascarillas caseras en la pandemia de COVID-19: recomendaciones, características físicas, desinfección y eficacia de uso / Máscaras caseiras na pandemia de COVID-19: recomendações, características físicas, desinfecção e eficácia de uso

Objective: To describe the recommendations, physical characteristics, methods of disinfection and the effectiveness of using homemade masks in reducing the transmission of COVID-19. Methods: Search was performed in the MEDLINE, SciELO and Google Scholar databases, in addition to the official recommendations for use. Results: 31 references were included. The filtration capacity of tissues varied between 5 and 98%. 100% cotton fabrics in two or three layers showed filtration efficiency between 70 and 99%, in vitro. Homemade masks, surgical and respirators showed breathability between 2.2 to 3.0 Pascal. The ability to reduce the spread of microorganisms by people wearing home masks was three times less than when using surgical masks, but it was superior to not wearing masks. Conclusion: The breathability of homemade masks may be adequate, while the filtration efficiency seems to be inferior to surgical masks, but superior to no mask use. There is no evidence to support the efficacy and effectiveness of homemade masks.

Objetivo: Descrever as recomendações, características físicas, métodos de desinfecção e eficácia de uso de máscaras caseiras na redução da transmissão da COVID-19. Métodos: Realizou-se busca nas bases de dados MEDLINE, SciELO e Google Scholar, além das recomendações oficiais de uso. Resultados: Foram incluídas 31 referências. A capacidade de filtração de tecidos variou entre 5 e 98%. Tecidos 100% algodão em duas ou três camadas apresentaram eficácia de filtração entre 70 e 99% em estudos in vitro. Máscaras caseiras, cirúrgicas e respiradores apresentaram respirabilidade entre 2,2 e 3,0 Pascal. A capacidade de redução da propagação de microrganismos por pessoas usando máscaras caseiras foi três vezes menor do que ao usar máscaras cirúrgicas, embora tenha sido superior ao não uso de máscaras. Conclusão: A respirabilidade de máscaras caseiras mostrou-se adequada, enquanto a eficácia de filtração parece ser inferior à das máscaras cirúrgicas, mas superior a não usar máscara. Não há evidências que respaldem a eficácia e efetividade das máscaras caseiras. 

Máscaras caseiras na pandemia de COVID-19: recomendações, características físicas, desinfecção e eficácia de uso / Mascarillas caseras en la pandemia de COVID-19: recomendaciones, características físicas, desinfección y eficacia de uso / Homemade masks in the COVID-19 pandemic: recommendations, physical characteristics, disinfection and efficacy

Objetivo: Descrever as recomendações, características físicas, métodos de desinfecção e eficácia de uso de máscaras caseiras na redução da transmissão da COVID-19. Métodos: Realizou-se busca nas bases de dados MEDLINE, SciELO e Google Scholar, além das recomendações oficiais de uso. Resultados: Foram incluídas 31 referências. A capacidade de filtração de tecidos variou entre 5% e 98%. Tecidos 100% algodão em duas ou três camadas apresentaram eficácia de filtração entre 70% e 99% em estudos in vitro. Máscaras caseiras, cirúrgicas e respiradores apresentaram respirabilidade entre 2,2 e 3,0 Pascal. A capacidade de redução da propagação de microrganismos por pessoas usando máscaras caseiras foi três vezes menor do que usando máscaras cirúrgicas, embora tenha sido superior ao não uso de máscaras. Conclusão: A respirabilidade de máscaras caseiras mostrou-se adequada, enquanto a capacidade de filtração parece ser inferior à das máscaras cirúrgicas, mas superior a não se usar máscara. Não há evidências que respaldem a eficácia e efetividade das máscaras caseiras.

Objetivo: Describir las recomendaciones, características físicas, métodos de desinfección y efectividad de mascarillas caseras para reducir la transmisión de COVID-19. Métodos: La búsqueda se realizó en las bases de datos MEDLINE, SciELO y Google Scholar, además de las recomendaciones oficiales de uso. Resultados: Se incluyeron 31 referencias. La capacidad de filtración de los tejidos varió entre 5% y 98%. Los tejidos al 100% de algodón, en dos o tres capas, mostraron eficiencia de filtración entre 70% y 99%, en estudios in vitro. Mascarillas caseras, quirúrgicas y de respiradores mostraron respirabilidad entre 2,2 y 3,0 Pascal. La capacidad de reducir la propagación de microorganismos por personas que usan máscarillas caseras fue tres veces menor que cuando usaban mascarillas quirúrgicas, pero superior a no usarlas. Conclusión: La respirabilidad de las mascarillas caseras puede ser adecuada, mientras que la eficiencia de filtración parece ser inferior a la de las mascarillas quirúrgicas, pero superior a no utilizar mascarilla. No hay evidencia que respalde su eficacia y efectividad.

Objective: To describe the recommendations, physical characteristics, disinfection methods and efficacy of the use of homemade face masks to reduce COVID-19 transmission. Methods: We searched MEDLINE, SciELO, and Google Scholar, in addition to the official recommendations for the use of masks. Results: Thirty-one references were included. Fabric filtration efficiency ranged from 5% to 98%. The filtration efficacy of three layered 100% cotton fabric face masks ranged from 70% and 99% in vitro studies. Homemade, surgical, and respirator masks showed breathability between 2.2 and 3.0 Pascal. The capacity to reduce the spread of microorganisms by people wearing homemade face masks was three times lower when compared to those wearing surgical masks, although this capacity was higher when compared to those who did not wear masks. Conclusion: The breathability of homemade masks proved to be adequate, while the filtration ability seemed to be lower than that of surgical masks, but it was better than not wearing any masks at all. There is no evidence to support the efficacy and effectiveness of homemade masks.

Avaliação da experiência odontológica prévia, hábitos alimentares e de higiene bucal em pacientes com paralisia cerebral / Evaluation of previous dental experience, eating habits and oral hygiene in patients with cerebral palsy

Avaliar descritivamente a experiência odontológica prévia, práticas de higiene bucal e hábitos alimentares de pacientes com Paralisia Cerebral (PC). Foi realizado um estudo observacional, do tipo transversal, com pacientes diagnosticados com PC através uma amostra de conveniência (n=27), com idade entre 3 e 14 anos, de ambos os sexos, que buscaram atendimento no ambulatório de pediatria do Hospital Universitário Materno Infantil, em São Luís ­ MA, no período de julho a outubro de 2018. Foi aplicado um questionário estruturado ao cuidador contendo história médica e odontológica da criança, avaliando também as práticas de higiene bucal e hábitos alimentares. Verificou-se que 66.67% dos pacientes eram do sexo masculino, com média de idade de 8,5 anos. Todos os acompanhantes eram do sexo feminino e a maior parte apresentou baixa escolaridade. Dentro os participantes, 92,59% não apresentavam habilidade para realizar escovação dentária e 51,85% dos cuidadores nunca receberam orientação sobre os cuidados de higiene bucal; 70,37% dos participantes fazem o consumo de alimentos açucarados e pastosos, e mais da metade já tiveram experiência de cárie. O estudo mostrou deficiência na higienização e um alto consumo de açúcar. Nesse sentido, práticas de higiene bucal e instruções dietéticas devem ser reforçadas e orientadas aos cuidadores a fim de contribuir para melhor assistência e prevenção à saúde.

Descriptively evaluate the previous dental experience, oral hygiene practices and eating habits of patients with Cerebral Palsy (CP). An observational, cross-sectional study was carried out with patients diagnosed with CP through a convenience sample (n = 27), aged between 0 and 18 years, of both sexes, who sought care at the pediatric outpatient clinic of Materno Infantile University Hospital, at Federal University of Maranhão, in São Luís - MA, from July to October 2018. A structured questionnaire was applied to the caregiver containing the child's medical and dental history, also evaluating oral hygiene practices and eating habits. It was found that 66.67% of the patients were male, with a mean age of 8.5 years. All companions were female and most had low education. Within the participants, 92.59% did not have the ability to perform tooth brushing and 51.85% of the caregivers never received guidance on oral hygiene care; 70.37% of participants consume sugary and pasty foods, and more than half have had caries experience. The study showed poor hygiene and a high consumption of sugar. In this sense, oral hygiene practices and dietary instructions should be reinforced and oriented to caregivers in order to contribute to better health care and prevention.

Clinical profile, anatomical features and long-term outcome of acute coronary syndromes in human immunodeficiency virus-infected patients.

BACKGROUND: Long-term prognosis of acute coronary syndromes (ACS) in human immunodeficiency virus (HIV)-infected patients is unknown. AIMS: To compare outcomes after ACS in HIV-infected and uninfected patients. METHODS: Retrospective observational study. HIV cases were matched with two HIV-uninfected controls for age, sex and type of ACS. RESULTS: In 92 HIV patients (mean age 51.3 ± 9.0 years, 7.6% women), the prevalence of cardiovascular risk factors was high (smoking 71.7%; hypertension 41.3%; diabetes 14.1%); dyslipidaemia was more frequent (53 (57.6%) vs 79 (42.9%), P = 0.02) and obesity less common (8 (8.7%) vs 41 (22.3%), P = 0.002) than in controls. Eighty-seven (94.6%) HIV patients had undetectable viral load and 85 (92.4%) were under anti-retroviral therapy. Multivessel disease was more common in HIV patients than in controls (44 (47.8%) vs 71 (39.1%); P = 0.05) as was Killip class 3-4 on admission (9 (9.8%) vs 6 (3.3%); P = 0.04). The rate of in-hospital mortality was similar in both groups (2%), and there were no significant differences in 3-year mortality (10.2% vs 5.7%; P = 0.27). Non-cardiovascular readmissions at 3 years were more frequent in HIV patients than in controls (36.5% vs 7.4%; P < 0.001). Multivariate analysis identified previous coronary artery disease as the strongest predictor of mortality in HIV patients (hazard ratio 4.7, 95% confidence interval 1.4-15.7, P = 0.01), whereas HIV infection was not associated with prognosis. CONCLUSION: HIV patients with ACS had more frequent multivessel disease and heart failure than matched controls. However, in-hospital and long-term mortality was similar in both groups. Non-cardiovascular re-hospitalisations were more common in HIV patients.

Implicações clínicas do uso de AINES em pacientes hipertensos: interações medicamentosas na odontologia / Clinical implications of NSAIDS use in hypertensive patients: drugs interactions in dentistry

Objetivo: Abordar as interações medicamentosas de interesse para a Odontologia entre os fármacos anti-hipertensivos (AH), mais utilizados pelos pacientes, e os medicamentos mais prescritos pelos alunos e profissionais, os Anti-Inflamatórios Não Esteroidais (AINEs). Método: Foi realizado um levantamento em 620 fichas de prontuários de pacientes atendidos nas clínicas do curso de Odontologia da Universidade Federal do Maranhão, no período de 2013 a 2017. Os dados obtidos foram tabulados e submetidos à análise estatística descritiva. Resultados: A classe de fármacos mais utilizada pelos pacientes com alterações sistêmicas foi a dos anti-hipertensivos (AH) (61,9%), sendo os mais usados a losartana (49,1%), captopril (19,29%), hidroclorotiazida (14,03%), atenolol (10,52%), anlodipina (8,77%) e enalapril (8,77%). Dentre os medicamentos mais prescritos pelos alunos e profissionais estavam os AINEs, como o paracetamol (78,28%), ibuprofeno (26,84%), dipirona (24,49%), nimesulida (13,42%) e diclofenaco (3,35%). Conclusão: O mecanismo de interação entre essas duas classes de medicamentos é do tipo farmacodinâmico de efeito, podendo reduzir a resposta anti-hipertensiva dos fármacos. Acredita-se estar relacionada principalmente à inibição das prostaglandinas renais pelos AINEs. Entretando, o uso a curto prazo (3-5 dias) não oferece riscos significativos aos pacientes com Hipertensão Arterial controlada.

Objetives: Approach the drug interactions that matter to Dentistry between the antihypertensive medicines (AH), more used by patients, and the drugs that are more prescribed by the Dentistry, the non-steroidal anti-inflammatory drugs (NSAIDs). Method: It was realized a survey study in 620 medical records of patients who were assisted in the University of Maranhão Dentistry School's dental offices, in the period from 2013 to 2017. The data were tabulated and submitted to descriptive statistical analysis. Results: The class of drugs more used by patients with systemic alterations was the antihypertensive medicines (AH) (61,9%), being more used the losartan (49,1%), captopril (19,29%), hidroclorotiazide (14,03%), atenolol (10,52%), anlodipine (8,77%) and enalapril (8,77%). Among the more prescribed by students and professionals were the NSAIDs, like acetaminofeno (78,28%), ibuprofen (26,84%), metamizol (24,49%), nimesulide (13,42%) and diclofenac (3,35%). Conclusion: The mechanism of interaction between these two classes of medicines is of the pharmacodynamic effect type, which may reduce the antihypertensive response of the drugs. It is believed to be mainly related to the inhibition of renal prostaglandins by NSAIDs. However, short-term use (3-5 days) does not offer significant risks to patients with controlled hypertension.

Desarrollo y validación externa de un modelo pronóstico precoz para supervivientes de una parada cardiaca extrahospitalaria / Development and external validation of an early prognostic model for survivors of out-of-hospital cardiac arrest

Introducción y objetivos: A pesar del uso de la hipotermia terapéutica, los pacientes recuperados tras sufrir una parada cardiaca extrahospitalaria tienen un elevado riesgo de muerte o deterioro neurológico grave. Se analizaron la utilidad de diversas variables disponibles al ingreso hospitalario para predecir su evolución a los 6 meses. Métodos: Se desarrolló un estudio multicéntrico en 3 unidades de cuidados intensivos cardiacos. El análisis se realizó sobre 153 pacientes ingresados en dos centros tras sufrir una parada cardiaca extrahospitalaria recuperada y que se trataron con control de temperatura, entre enero de 2007 y julio de 2015. Se consideraron secuelas neurológicas significativas si la Cerebral Performance Categories Scale > 2 a los 6 meses. Los resultados se validaron externamente con los datos procedentes de otros 91 pacientes ingresados en un tercer hospital, durante el mismo periodo de tiempo. Resultados: Del total de 244 pacientes (mediana de edad, 60 años; 77,1% varones; 50,0% en el contexto de isquemia miocárdica aguda), 107 (43,8%) sobrevivieron a los 6 meses con una evolución neurológica favorable. Se calculó un modelo predictivo que incluyó 5 variables (primer ritmo, edad, lactato al ingreso, tiempo hasta recuperación de circulación espontánea y diabetes), con un área bajo la curva de 0,90 (IC95%, 0,85-0,95). Cuando se realizó la validación externa del modelo, la sensibilidad fue de 73,5%, con una especificidad de 78,6% y un área bajo la curva de 0,82 (IC95%, 0,73-0,91). Conclusiones: Un modelo predictivo que incluye cinco variables disponibles en el momento de ingreso de pacientes recuperados tras sufrir una parada cardiaca extrahospitalaria puede ayudar a predecir la probabilidad de supervivencia libre de secuelas neurológicas graves en el seguimiento

Introduction and objectives: Despite therapeutic hypothermia, unconscious survivors of out-of-hospital cardiac arrest have a high risk of death or poor neurologic function. Our objective was to assess the usefulness of the variables obtained in the early moments after resuscitation in the prediction of 6-month prognosis. Methods: A multicenter study was performed in 3 intensive cardiac care units. The analysis was done in 153 consecutive survivors of out-of-hospital cardiac arrest who underwent targeted temperature management between January 2007 and July 2015. Significant neurological sequelae at 6 months were considered to be present in patients with Cerebral Performance Categories Scale > 2. An external validation was performed with data from 91 patients admitted to a third hospital in the same time interval. Results: Among the 244 analyzed patients (median age, 60 years; 77.1% male; 50.0% in the context of acute myocardial ischemia), 107 patients (43.8%) survived with good neurological status at 6 months. The prediction model included 5 variables (Shockable rhythm, Age, Lactate levels, Time Elapsed to return of spontaneous circulation, and Diabetes - SALTED) and provided an area under the curve of 0.90 (95%CI, 0.85-0.95). When external validation was performed, the predictive model showed a sensitivity of 73.5%, specificity of 78.6%, and area under the curve of 0.82 (95%CI, 0.73-0.91). Conclusions: A predictive model that includes 5 clinical and easily accessible variables at admission can help to predict the probability of survival without major neurological damage following out-of-hospital cardiac arrest

Tako-tsubo cardiomyopathy triggered by multiple shocks in electrical storm.

Tako-tsubo cardiomyopathy (TTC) is a syndrome characterized by acute transient ventricular dysfunction in the absence of obstructive coronary artery disease and is predominantly associated with exposure to sudden emotional or physical stress. Patients with TTC may develop serious in-hospital complications, including ventricular arrhythmias. However, triggering of TTC after an electrical storm has not previously been described. We present two cases of TTC induced by multiple shocks in the setting of an electrical storm due to pharmacologically induced long QT syndrome.

Development and External Validation of an Early Prognostic Model for Survivors of Out-of-hospital Cardiac Arrest.

INTRODUCTION AND OBJECTIVES: Despite therapeutic hypothermia, unconscious survivors of out-of-hospital cardiac arrest have a high risk of death or poor neurologic function. Our objective was to assess the usefulness of the variables obtained in the early moments after resuscitation in the prediction of 6-month prognosis. METHODS: A multicenter study was performed in 3 intensive cardiac care units. The analysis was done in 153 consecutive survivors of out-of-hospital cardiac arrest who underwent targeted temperature management between January 2007 and July 2015. Significant neurological sequelae at 6 months were considered to be present in patients with Cerebral Performance Categories Scale > 2. An external validation was performed with data from 91 patients admitted to a third hospital in the same time interval. RESULTS: Among the 244 analyzed patients (median age, 60 years; 77.1% male; 50.0% in the context of acute myocardial ischemia), 107 patients (43.8%) survived with good neurological status at 6 months. The prediction model included 5 variables (Shockable rhythm, Age, Lactate levels, Time Elapsed to return of spontaneous circulation, and Diabetes - SALTED) and provided an area under the curve of 0.90 (95%CI, 0.85-0.95). When external validation was performed, the predictive model showed a sensitivity of 73.5%, specificity of 78.6%, and area under the curve of 0.82 (95%CI, 0.73-0.91). CONCLUSIONS: A predictive model that includes 5 clinical and easily accessible variables at admission can help to predict the probability of survival without major neurological damage following out-of-hospital cardiac arrest.

Infections in patients after Berlin Heart® EXCOR assist device implantation.

OBJECTIVES: Berlin Heart® EXCOR devices (BHED) are ventricular assist devices (VAD) used mainly as a bridge to heart transplantation (HT) in pediatric population. The aim of our study is to report the infections diagnosed in adult patients undergoing a BHED implantation. METHODS: Adult patients receiving a BHED between Jul 2009 and Oct 2017 at our institution were included. Infections were classified according to the International Society of Heart and Lung Transplantation definitions in VAD-Specific (VAD-S), VAD-Related (VAD-R) and non-VAD (N-VAD). RESULTS: Fifteen patients underwent BHED implantation, which was maintained for a mean of 92 (19-195) days. Infection occurred in 13 patients who developed 36 infectious episodes: 5 VAD-S (5 cannula infections); 8 VAD-R (5 bloodstream infections and 3 mediastinitis) and 24 N-VAD (7 urinary tract infections, 6 Cytomegalovirus diseases and others). Overall, 27 (75%) were bacterial, 7 (19.4%) were viral and there was one (2.7%) fungal infection. Eleven patients underwent HT and all of them developed at least one infection after it. In 3 cases, all VAD-R or VAD-S infections were caused by the same etiology as before HT. Their median time of appearance was on day +6 (3-11) after BHED removal and HT. Overall mortality was 6/15 (40%). None of the deaths were related to VAD Infection. CONCLUSIONS: Infection complicated BHED implantation in 86.7% of the patients. Overall, 13.9% were specific of BHED and 22.2% were related. However, infections did not preclude HT in any case and carried no attributable mortality.

Registro Español de Trasplante Cardiaco. XXVII Informe Oficial de la Sección de Insuficiencia Cardiaca y Trasplante Cardiaco de la Sociedad Española de Cardiología (1984-2015) / Spanish Heart Transplantation Registry. 27th Official Report of the Spanish Society of Cardiology working group on Heart Failure and Heart Transplantation (1984-2015)

Introducción y objetivos: Se presentan las características y los resultados del trasplante cardiaco en España desde que empezó su actividad en mayo de 1984. Métodos: Se realiza un análisis descriptivo de las características de los receptores, los donantes, los procedimientos quirúrgicos y los resultados de los trasplantes cardiacos realizados en España hasta el 31 de diciembre de 2015. Resultados: Durante 2015 se han realizado 299 procedimientos, con lo que la serie histórica consta de 7.588 trasplantes. Las características generales del procedimiento son similares a las observadas en los últimos años y destacan el alto porcentaje de procedimientos realizados en código urgente y, sobre todo, la extensión del uso de dispositivos de asistencia circulatoria, particularmente la asistencia ventricular de flujo continuo (el 16% del total de trasplantes). La supervivencia ha aumentado significativamente en la última década con respecto a periodos anteriores. Conclusiones: La actividad de trasplante cardiaco en España permanece estable en los últimos años, con alrededor de 250-300 procedimientos al año. A pesar de la mayor complejidad del contexto clínico, se observa una mejora de la supervivencia en los últimos años (AU)

Introduction and objectives: The present article reports the characteristics and results of heart transplants in Spain since this therapeutic modality was first used in May 1984. Methods: We describe the main features of recipients, donors, surgical procedures, and results of all heart transplants performed in Spain until December 31, 2015. Results: A total of 299 cardiac transplants were performed in 2015, with the whole series comprising 7588 procedures. The main transplant features in 2015 were similar to those observed in recent years. A remarkably high percentage of transplants were performed under emergency conditions and there was widespread use of circulatory assist devices, particularly continuous-flow left ventricular assist devices prior to transplant (16% of all transplants). Survival has significantly improved in the last decade compared with previous time periods. Conclusions: During the last few years, between 250 and 300 heart transplants have consistently been performed each year in Spain. Despite a more complex clinical context, survival has increased in recent years (AU)

Spanish Heart Transplantation Registry. 27th Official Report of the Spanish Society of Cardiology Working Group on Heart Failure and Heart Transplantation (1984-2015).

INTRODUCTION AND OBJECTIVES: The present article reports the characteristics and results of heart transplants in Spain since this therapeutic modality was first used in May 1984. METHODS: We describe the main features of recipients, donors, surgical procedures, and results of all heart transplants performed in Spain until December 31, 2015. RESULTS: A total of 299 cardiac transplants were performed in 2015, with the whole series comprising 7588 procedures. The main transplant features in 2015 were similar to those observed in recent years. A remarkably high percentage of transplants were performed under emergency conditions and there was widespread use of circulatory assist devices, particularly continuous-flow left ventricular assist devices prior to transplant (16% of all transplants). Survival has significantly improved in the last decade compared with previous time periods. CONCLUSIONS: During the last few years, between 250 and 300 heart transplants have consistently been performed each year in Spain. Despite a more complex clinical context, survival has increased in recent years.

Early intravenous immunoglobulin replacement in hypogammaglobulinemic heart transplant recipients: results of a clinical trial.

BACKGROUND: Immunoglobulin G (IgG) hypogammaglobulinemia (HGG) is a risk factor for development of severe infections after heart transplantation. We performed a clinical trial to preliminarily evaluate the efficacy and safety of early administration of intravenous immunoglobulin (IVIG) for prevention of severe infection in heart recipients with post-transplant IgG HGG. METHODS: Twelve heart recipients with IgG HGG detected in a screening phase of the clinical trial (IgG <500 mg/dL) were recruited. Patients received IVIG (Flebogamma 5%), as follows: 2 doses of 200 mg/kg followed by up to 5 additional doses of 300 mg/kg to maintain IgG >750 mg/dL. IgG and specific antibody titers to distinct microorganisms were tested during follow-up. The primary outcome measure was development of severe infection during the study period. Data on the primary outcome were matched with those of 13 recipients with post-transplant HGG who were not included in the clinical trial and with those of 11 recipients who did not develop HGG during the same study period. RESULTS: Mean time to detection of HGG was 15 days. IgG and specific antibody reconstitution (anti-cytomegalovirus, anti-Haemophilus influenza, and anti-hepatitis B surface antigen antibodies) was observed in IVIG-treated patients. Severe infection was detected in 3 of 12 (25%) IVIG-treated recipients, in 10 of 13 (77%) HGG non-IVIG patients, and in 2 of 11 (18%) non-HGG patients (log-rank, 15.31; P=.0005). No severe IVIG-related side effects were recorded. CONCLUSION: Data from this study demonstrate that prophylactic IVIG replacement therapy safely modulates HGG and specific antimicrobial antibodies. Our data also preliminarily suggest that IVIG replacement therapy might decrease the incidence of severe infection in heart recipients with HGG.

Impact of time to cooling initiation and time to target temperature in patients treated with hypothermia after cardiac arrest.

PURPOSE: Little is known about the role of time to initiation of therapeutic hypothermia and time to target temperature (TTT) in the prognosis of patients resuscitated from cardiac arrest. METHODS: A retrospective analysis was performed in 145 survivors of cardiac arrest who underwent therapeutic hypothermia between January 2003 and January 2013. The objective was to identify predictors of survival free from significant neurological sequelae (Cerebral Performance Categories Scale (CPC): >2) six months after cardiac arrest. We evaluated the effect of faster and earlier cooling. RESULTS: Overall survival at six months was 42.1% (61 patients); 59 of these were considered to have a good neurological status (CPC ≤ 2), and in whom therapeutic hypothermia was initiated earlier (87 ± 17 min vs. 111 ± 14 min; p=0.042), and the target temperature was reached at an earlier time (TTT: 316 ± 30 min vs. 365 ± 27 min; p=0.017). Multivariate analysis selected longer duration of cardiac arrest (odds ratio (OR) = 1.06 per min), a non-shockable initial rhythm (OR=13.8), severe acidosis (OR=0.009 per 0.01 unit), older age (OR=1.04 per year) and longer TTT (OR=1.005 per min) as associated with poor prognosis. CONCLUSION: The most important prognostic factors for death or lack of neurological recovery in patients with cardiac arrest treated with therapeutic hypothermia are initial-rhythm, time from cardiac arrest to return of spontaneous circulation and arterial-pH at admission. Although the speed of cooling initiation and the time to reach target temperature may play a role, its influence on prognosis seems to be less important.